Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-09-19FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved a generic palonosetron hydrochloride product from Mylan Institutional LLC through an original ANDA, intended to prevent postope…
-
FDA approval · 2018-09-19FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved Palonosetron hydrochloride as a generic product through an Original Application filed by Sagent Pharmaceuticals.
-
FDA approval · 2018-09-19FDA Approved: PALONOSETRON — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original application for a generic palonosetron hydrochloride product to prevent chemotherapy- and surgery-induc…
-
FDA approval · 2018-04-23FDA Approved: ONDANSETRON — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for ondansetron hydrochloride from Taro Pharmaceuticals U.S.A., Inc., for an already approved pr…
-
FDA approval · 2018-03-23FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Teva Parenteral Medicines, Inc.)
FDA approved Teva Parenteral Medicines' palonosetron hydrochloride injection as an original application (ANDA 090713), establishing bioequiv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-03-14FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for ondansetron hydrochloride from Chartwell RX, LLC, under the ANDA process.
-
FDA approval · 2018-03-07FDA Approved: ONDANSETRON — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for ondansetron under an ANDA held by PAI Holdings dba PAI Pharma, indicating a supplemental reg…
-
FDA approval · 2018-03-07FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride from Aurobindo Pharma Limited, granting approval of this generic p…
-
FDA approval · 2018-03-07FDA Approved: ONDANSETRON — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for ondansetron hydrochloride (ONDANSETRON) from NorthStar Rx LLC, resulting in updated labeling for…
-
FDA approval · 2018-03-07FDA Approved: ONDANSETRON — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for ondansetron from Rising Pharma Holdings, Inc., marking an update to the generic's labeling or po…
-
FDA approval · 2018-02-26FDA Approved: ONDANSETRON — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for ondansetron filed by Chartwell RX, LLC.
-
FDA approval · 2018-02-26FDA Approved: ONDANSETRON — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for ondansetron submitted by Chartwell RX, LLC, approving a generic ondansetron product.
-
FDA approval · 2018-02-13FDA Approved: ONDANSETRON — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for ondansetron submitted by Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2018-02-13FDA Approved: ONDANSETRON — Supplemental Application (AvKARE)
FDA approved a supplemental application for AvKARE's ondansetron, a generic antiemetic, indicating an addition or modification to the approv…
-
FDA approval · 2017-12-14FDA Approved: DROPERIDOL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a generic version of droperidol under an original application by Hikma Pharmaceuticals USA Inc. This approval adds another gene…
-
FDA approval · 2017-09-13FDA Approved: TRANSDERM SCOP — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for Transderm Scop (scopolamine) from Baxter Healthcare Corporation.
-
FDA approval · 2017-09-13FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)
FDA approved Cumberland Pharmaceuticals' supplemental application for SANCUSO (granisetron). The granisetron product is used to prevent chem…
-
FDA approval · 2017-07-17FDA Approved: TRANSDERM SCOP — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for TRANSDERM SCOP (scopolamine) from Baxter Healthcare Corporation. This action updates the lab…
-
FDA approval · 2017-05-31FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for EMEND (aprepitant) filed by Merck Sharp & Dohme LLC.
-
FDA approval · 2017-03-30FDA Approved: ONDANSETRON — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark Pharmaceuticals’ supplemental application for ondansetron (generic antiemetic) under ANDA077535.
-
FDA approval · 2017-03-27FDA Approved: ONDANSETRON — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for ondansetron submitted by Rising Pharma Holdings, Inc.
-
FDA approval · 2017-03-24FDA Approved: ONDANSETRON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for ondansetron from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2017-03-24FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ondansetron hydrochloride from Sun Pharmaceutical Industries, Inc., under the ANDA.
-
FDA approval · 2017-02-23FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approved a supplemental application for Prochlorperazine maleate by Jubilant Cadista Pharmaceuticals Inc.
-
FDA approval · 2017-02-14FDA Approved: ONDANSETRON — Supplemental Application (ACTAVIS PHARMA, INC.)
The FDA approved a supplemental application for ondansetron tablets from Actavis Pharma, Inc. under the ANDA, signifying an approved change …